Traitements3programmes
Essais2liés
Publications0liées
SourceDBlocale

Traitements

3
MoléculeIndication / populationPhaseObjectifPaysRésultat
CoolStat active deviceThis is a prospective, double-blind, sham-controlled, randomized study to assess the safety, tolerability, and optimal dose of the COOLSTAT Transnasal Thermal Regulating Device for acute treatment of migraine. The hypothesis is that evaporative cooling induced by the CoolStat using only ambient, dry air will reduce the pain and other symptoms of migraine headaches during an acute migraine episode. Migraine Non applicable Traitement symptomatique United States À vérifier
CoolStat sham deviceThis is a prospective, double-blind, sham-controlled, randomized study to assess the safety, tolerability, and optimal dose of the COOLSTAT Transnasal Thermal Regulating Device for acute treatment of migraine. The hypothesis is that evaporative cooling induced by the CoolStat using only ambient, dry air will reduce the pain and other symptoms of migraine headaches during an acute migraine episode. Migraine Non applicable Traitement symptomatique United States À vérifier
CoolStat active deviceThis is a prospective, double-blind, sham-controlled, randomized study to assess the safety, tolerability, and optimal dose of the COOLSTAT Transnasal Thermal Regulating Device for acute treatment of migraine. The hypothesis is that evaporative cooling induced by the CoolStat using only ambient, dry air will reduce the pain and other symptoms of migraine headaches during an acute migraine episode. Migraine Non applicable Traitement symptomatique United States À vérifier

Essais cliniques

2
MoléculeIndication / populationPhaseNCTTitreStatut
CoolStat active device Migraine Non applicable NCT04936061 Transnasal Cooling for Migraine TERMINATED
Mi-Helper Migraine Non applicable NCT06051604 Mi-Helper Transnasal Cooling for Acute Treatment of Migraine COMPLETED

Publications

0
MoléculeIndication / populationTitreJournalDate
Aucune publication.